Pneumocystis carinii is resistant to imidazole antifungal agents.
AUTOR(ES)
Bartlett, M S
RESUMO
Because Pneumocystis carinii is closely related to fungi, drugs useful for treating mycoses have been considered for use in the treatment of P. carinii pneumonia. Six antifungal imidazole drugs were tested for their activities against P. carinii in a short-term culture screen and in animals. None of the imidazoles tested was effective in inoculated infected rats, and only miconazole showed slight effects in culture at the high concentration of 10 micrograms/ml. Analysis of cell membranes from culture-grown P. carinii showed that ergosterol, the target for this class of antifungal agents, was absent, so that the lack of effect of these agents is rational.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=284650Documentos Relacionados
- A cytotoxicity assay for evaluation of candidate anti-Pneumocystis carinii agents.
- Biological profile and response to anti-pneumocystis agents of Pneumocystis carinii in cell culture.
- Novel synergism of two antifungal agents, copiamycin and imidazole.
- Iron chelators as therapeutic agents against Pneumocystis carinii.
- Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro.
